Novel roles for mucin 1 in the kidney
dc.contributor.author | Al-bataineh, Mohammad | |
dc.contributor.author | Sutton, Timothy A. | |
dc.contributor.author | Hughey, Rebecca P. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2018-02-09T15:15:36Z | |
dc.date.available | 2018-02-09T15:15:36Z | |
dc.date.issued | 2017-09 | |
dc.description.abstract | Purpose of review Recent studies in the kidney have revealed that the well characterized tumor antigen mucin 1 (MUC1/Muc1) also has numerous functions in the normal and injured kidney. Recent findings Mucin 1 is a transmembrane mucin with a robust glycan-dependent apical targeting signal and efficient recycling from endosomes. It was recently reported that the TRPV5 calcium channel is stabilized on the cell surface by galectin-dependent cross-linking to mucin 1, providing a novel mechanism for regulation of ion channels and normal electrolyte balance. Our recent studies in mice show that Muc 1 is induced after ischemia, stabilizing hypoxia-inducible factor 1 (HIF-1)α and β-catenin levels, and transactivating the HIF-1 and β-catenin protective pathways. However, prolonged induction of either pathway in the injured kidney can proceed from apparent full recovery to chronic kidney disease. A very recent report indicates that aberrant activation of mucin 1 signaling after ischemic injury in mice and humans is associated with development of chronic kidney disease and fibrosis. A frameshift mutation in MUC1 was recently identified as the genetic lesion causing medullary cystic kidney disease type 1, now appropriately renamed MUC1 Kidney Disease. Summary Studies of mucin 1 in the kidney now reveal significant functions for the extracellular mucin-like domain and signaling through the cytoplasmic tail. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Al-bataineh, M. M., Sutton, T. A., & Hughey, R. P. (2017). Novel roles for mucin 1 in the kidney. Current Opinion in Nephrology and Hypertension, 26(5), 384. https://doi.org/10.1097/MNH.0000000000000350 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/15168 | |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer | en_US |
dc.relation.isversionof | 10.1097/MNH.0000000000000350 | en_US |
dc.relation.journal | Current Opinion in Nephrology and Hypertension | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | mucin 1 | en_US |
dc.subject | kidney disease | en_US |
dc.subject | acute kidney injury | en_US |
dc.title | Novel roles for mucin 1 in the kidney | en_US |
dc.type | Article | en_US |